|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Jan 1, 2023
|
FY2021
12 months to Jan 2, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation expense | |||||
| Amortization of intangible assets | |||||
| Share-based compensation expense | |||||
| Accretion of debt discount on convertible senior notes | |||||
| Deferred income taxes | |||||
| Gain on previously held investment in GRAIL | |||||
| Gain on exchange of GRAIL contingent value rights | |||||
| Net (gains) losses on strategic investments | |||||
| Change in fair value of contingent consideration liabilities | |||||
| Unrealized loss on foreign exchange translation | |||||
| Goodwill and intangible impairment | |||||
| Property and equipment and right-of-use asset impairment | |||||
| Non-cash charitable contribution | |||||
| Gain on Helix contingent value right | |||||
| Payment of accreted debt discount | |||||
| Gain on derivative assets related to terminated acquisition | |||||
| Goodwill and intangible (IPR&D) impairment | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Operating lease right-of-use assets and liabilities, net | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Maturities of available-for-sale securities | |||||
| Purchases of available-for-sale securities | |||||
| Sales of available-for-sale securities | |||||
| Net purchases of property and equipment | |||||
| Net sales (purchases) of strategic investments | |||||
| Cash received for derivative assets related to terminated acquisition | |||||
| Cash paid for acquisitions and intangible assets, net of cash acquired | |||||
| Cash paid for intangible asset | |||||
| Cash received for Helix contingent value right | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Common stock repurchases | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Proceeds from issuance of common stock | |||||
| Payments on contingent consideration liabilities | |||||
| Proceeds from debt, net of issuance costs | |||||
| Payments on debt obligations | |||||
| GRAIL cash deconsolidated as a result of spin-off | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes (see Note 10) | |||||
| Cash paid for operating lease liabilities | |||||
| Purchases of property and equipment included in accounts payable and accrued liabilities | |||||
| GRAIL net assets, excluding cash and cash equivalents, deconsolidated as a result of spin-off | |||||
Loading...